Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946217 · ClinicalTrials.gov registry record
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
A clinical trial of HIV Infection and Malignant Neoplasm, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 82
- Enrollment target
- 14
- Study locations
NCT01946217 is a study of HIV Infection and Malignant Neoplasm that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 82 participants, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (66% lower). The trial reports 14 study locations across 6 states.
The verdict
NCT01946217, a study of HIV Infection and Malignant Neoplasm, has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
- 14
- Study locations
Study Summary
This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.
Conditions Studied
Interventions
- OTHER questionnaire administration
Study Locations (14)
New York
- Laser Surgery Care - New York
- Memorial Sloan-Kettering Cancer Center - New York
- Albert Einstein Cancer Center at Albert Einstein College of Medicine - The Bronx
- Montefiore-Einstein Cancer Center - The Bronx
- Montefiore Medical Center - The Bronx
Louisiana
- Interim LSU Public Hospital - New Orleans
- HIV Out-patient Clinic - New Orleans
- NO AIDS Clinic - New Orleans
Washington
- Virginia Mason Medical Center - Seattle
- Harborview Madison Clinic - Seattle
- Seattle Cancer Care Alliance - Seattle
California
- UCLA Clinical AIDS Research and Education (CARE) Center - Los Angeles
Illinois
- Stroger Hospital of Cook County - Chicago
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01946217
The ClinicalTrials.gov registry entry for NCT01946217 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (66% lower). The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which questionnaire administration is the first listed.
NCT01946217 reports 14 study locations spanning 6 distinct geographic areas - top geographies include New York, Louisiana, Washington.
Frequently Asked Questions
What is clinical trial NCT01946217 about?
NCT01946217 is a clinical study titled "Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials". This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in whi...
What is the current status of trial NCT01946217?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2013-09. Estimated completion is 2015-09.
What conditions does trial NCT01946217 study?
This clinical trial studies the following conditions: HIV Infection, Malignant Neoplasm, Precancerous Condition.
What interventions are being tested in trial NCT01946217?
The interventions under investigation include: questionnaire administration (OTHER).
Who is sponsoring clinical trial NCT01946217?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01946217 being conducted?
This trial has 14 study locations across California, Illinois, Louisiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
MAPS PrEP Van Study
RECRUITING · Phase 4
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.